Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedPublications section text updated to note PubMed auto-population of articles, and the page now displays Revision: v3.3.2. This replaces the earlier wording about PubMed publications and Revision: v3.2.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA government funding status notice was removed from the page.SummaryDifference0.3%

- Check35 days agoChange DetectedNo additions or deletions detected on the Study Details page for NCT02926833; the content and structure appear the same across the screenshots.SummaryDifference0.4%

- Check64 days agoChange Detected- Page now includes a government operating status notice and directs to official sources for updates. - Version updated from v3.1.0 to v3.2.0. - Adds a new resource topic: Malignant lymphoma, large B-cell, diffuse.SummaryDifference3%

- Check71 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2 (new release). The 'Back to Top' link was removed as a minor UI cleanup.SummaryDifference0.1%

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.